aid: cerevance
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/cerevance.png
name: Cerevance
description: 'Cerevance is a clinical-stage biopharmaceutical company developing novel therapeutics
  for central nervous system (CNS) disorders. Its proprietary NETSseq platform profiles gene
  expression across specific human brain cell types from post-mortem tissue to identify previously
  undiscovered, cell-type-specific drug targets, powering a pipeline of small-molecule candidates
  for Parkinson''s disease, Alzheimer''s disease, epilepsy, and other neurodegenerative and
  psychiatric conditions. Surfaced as a portfolio company of GV; profiled in the API Evangelist
  network. Cerevance publishes no public API, developer portal, or SDK.'
url: https://raw.githubusercontent.com/api-evangelist/cerevance/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- gv
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Life Sciences
- Biotechnology
- Pharmaceuticals
- Drug Discovery
- Central Nervous System
- Neuroscience
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.cerevance.com
- type: Blog
  url: https://www.cerevance.com/media
- type: Support
  url: https://www.cerevance.com/contact-cerevance
- type: PrivacyPolicy
  url: https://www.cerevance.com/privacy-policy
- type: TermsOfService
  url: https://www.cerevance.com/terms-of-use
- type: DomainSecurity
  url: security/cerevance-domain-security.yml
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence